AU2886292A - Compositions and methods for treatment of epstein-barr virus-associated diseases - Google Patents
Compositions and methods for treatment of epstein-barr virus-associated diseasesInfo
- Publication number
- AU2886292A AU2886292A AU28862/92A AU2886292A AU2886292A AU 2886292 A AU2886292 A AU 2886292A AU 28862/92 A AU28862/92 A AU 28862/92A AU 2886292 A AU2886292 A AU 2886292A AU 2886292 A AU2886292 A AU 2886292A
- Authority
- AU
- Australia
- Prior art keywords
- epstein
- compositions
- treatment
- methods
- barr virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000701044 Human gammaherpesvirus 4 Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78360591A | 1991-10-25 | 1991-10-25 | |
| US783605 | 1991-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2886292A true AU2886292A (en) | 1993-05-21 |
Family
ID=25129820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28862/92A Abandoned AU2886292A (en) | 1991-10-25 | 1992-10-23 | Compositions and methods for treatment of epstein-barr virus-associated diseases |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2886292A (en) |
| NZ (1) | NZ244820A (en) |
| WO (1) | WO1993007882A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU649734B2 (en) * | 1990-08-16 | 1994-06-02 | Isis Pharmaceuticals, Inc. | Inhibition of candida |
| AU656136B2 (en) * | 1990-04-20 | 1995-01-27 | General Hospital Corporation, The | Methods of preventing viral replication |
| US5610050A (en) * | 1990-04-20 | 1997-03-11 | The General Hospital Corporation | Methods of preventing viral replication |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789573A (en) * | 1990-08-14 | 1998-08-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 |
| AU1878895A (en) * | 1994-02-18 | 1995-09-04 | Hybridon, Inc. | Oligonucleotides with anti-respiratory syncytial virus activity |
| US5550047A (en) * | 1994-02-18 | 1996-08-27 | University Of Massachusetts | Oligonucleotides with anti-Epstein-Barr virus activity |
| GB9413035D0 (en) * | 1994-06-29 | 1994-08-17 | Scras | Antisense oligonucleeotides |
| US5837854A (en) * | 1996-04-05 | 1998-11-17 | University Of Massachusetts | Oligonucleotides with anti-Epstein-Barr virus activity |
| CA2321654C (en) | 1998-03-04 | 2011-02-15 | Marcel Bartolina Hendrikus Johannes Vervoort | Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid |
| CA2370108A1 (en) * | 1999-04-30 | 2000-11-09 | Advance Sentry Corporation | System and method for screening of nasopharyngeal carcinoma |
| US20070299027A1 (en) * | 2006-01-26 | 2007-12-27 | Gene Hung | Compositions and their uses directed to huntingtin |
| EP3342415B1 (en) | 2006-08-08 | 2022-01-26 | Rheinische Friedrich-Wilhelms-Universität Bonn | Structure and use of 5' phosphate oligonucleotides |
| JP5689413B2 (en) | 2008-05-21 | 2015-03-25 | ライニッシュ フリードリッヒ−ウィルヘルムズ−ユニバーシタット ボン | 5 'triphosphate oligonucleotide having blunt ends and uses thereof |
| EP2508530A1 (en) | 2011-03-28 | 2012-10-10 | Rheinische Friedrich-Wilhelms-Universität Bonn | Purification of triphosphorylated oligonucleotides using capture tags |
| EP2712870A1 (en) | 2012-09-27 | 2014-04-02 | Rheinische Friedrich-Wilhelms-Universität Bonn | Novel RIG-I ligands and methods for producing them |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
-
1992
- 1992-10-20 NZ NZ24482092A patent/NZ244820A/en unknown
- 1992-10-23 AU AU28862/92A patent/AU2886292A/en not_active Abandoned
- 1992-10-23 WO PCT/US1992/008989 patent/WO1993007882A1/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU656136B2 (en) * | 1990-04-20 | 1995-01-27 | General Hospital Corporation, The | Methods of preventing viral replication |
| US5610050A (en) * | 1990-04-20 | 1997-03-11 | The General Hospital Corporation | Methods of preventing viral replication |
| AU649734B2 (en) * | 1990-08-16 | 1994-06-02 | Isis Pharmaceuticals, Inc. | Inhibition of candida |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993007882A1 (en) | 1993-04-29 |
| NZ244820A (en) | 1994-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4214193A (en) | Bioadhesive treatment compositions and method of use | |
| AU6446490A (en) | Disinfectant composition and method of disinfection | |
| AU3368595A (en) | Methods of inhibiting demyelinating and dysmyelinating diseases | |
| AU2886292A (en) | Compositions and methods for treatment of epstein-barr virus-associated diseases | |
| AU8910891A (en) | Treatment of lung diseases | |
| AU7650396A (en) | Treatment and prophylaxis of osteoporosis | |
| AU5960394A (en) | Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases | |
| AU5605398A (en) | Novel methods and compositions for treatment of autoimmune diseases | |
| AU2180097A (en) | Composition for prevention and treatment of periodontal diseases | |
| AU8192691A (en) | Method of treatment and compositions therefore | |
| AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
| IL107768A0 (en) | Treatment of agricultural produce | |
| AU7609094A (en) | Treatment and prophylaxis of diseases caused by parasites or bacteria | |
| AU3263795A (en) | Medicament for treatment or prophylaxis of incontinence | |
| AUPN380695A0 (en) | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions | |
| AU3027692A (en) | Compositions for the treatment of mammalian diseases | |
| AU3607597A (en) | Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases | |
| AU4104093A (en) | Method and compositions for treatment of pyonecrotic processes | |
| AU7120987A (en) | Composition for and method of treating aids and certain related diseases | |
| AU5293293A (en) | Methods and compositions for treatment of allergic disease | |
| AU5425098A (en) | Compounds and methods to treat infectious diseases | |
| AU4819993A (en) | Drug for treatment and prophylaxis of bone and joint diseases | |
| AU4604697A (en) | Compositions and methods for the treatment of human cytomegalovirus infection | |
| AU2754997A (en) | The treatment of plant diseases | |
| AU4319393A (en) | Use of indolocarbazols in aids treatment |